Bristol-Myers Squibb, Sanofi strike out in bid to stop Plavix litigation [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Healthcare Bristol-Myers Squibb, Sanofi strike out in bid to stop Plavix litigation Mar. 20, 2020 3:12 PM ET | Bristol-Myers Squibb C... (BMY) Douglas W. House A Hawaii district court judge has dismissed a countersuit brought by Bristol-Myers Squibb ( +0.6% SNY -4.8% Judge Jill Otake said that the countersuit, if allowed, would be an "extraordinary" remedy of a federal court enjoining a state proceeding. The Plavix trial is set to begin May 5 but will likely be delayed due to the COVID-19 breakout. Hawaii is seeking more than $8B in fines. Click to subscribe to real-time analytics on BMY Now read: Bristol-Myers Squibb's Multiple Myeloma Setback, And Other News: The Good, Bad And Ugly Of Biopharma »
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb Canada Welcomes Positive CDA Recommendation for OPDIVO® Plus YERVOY® as First-Line Treatment for MSI-H/dMMR Metastatic Colorectal Cancer [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Advancium Health Network Names Michele Cleary CEO to Drive Next Phase of Pediatric Healthcare Innovation [Yahoo! Finance]Yahoo! Finance
- Why Bristol-Myers Squibb (BMY) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $61.00 price target on the stock, up previously from $52.00.MarketBeat
- How Investors May Respond To Bristol Myers (BMY) Dividend Hike And Oncology Pipeline Momentum [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website